drugset / Trial / NCT05619367

A Compassionate Use (CU) Program of Odronextamab

NCT05619367

Expanded access Available Regeneron Pharmaceuticals

Summary

Provide compassionate use of odronextamab

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Odronextamab Monoclonal antibody